Hu, Y., Zhi, H., Zhang, A., Lu, S., & Zhang, C. Systematic analysis identifies TRIM22 as an oncogenic and immunological biomarker in glioma. BMC.
Chicago Style (17th ed.) CitationHu, Yuanyuan, Haimei Zhi, Amin Zhang, Siyu Lu, and Chen Zhang. Systematic Analysis Identifies TRIM22 as an Oncogenic and Immunological Biomarker in Glioma. BMC.
MLA (9th ed.) CitationHu, Yuanyuan, et al. Systematic Analysis Identifies TRIM22 as an Oncogenic and Immunological Biomarker in Glioma. BMC.
Warning: These citations may not always be 100% accurate.